Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE Trial.
Andreassen AK, Broch K, Eiskjær H, Karason K, Gude E, Mølbak D, Stueflotten W, Gullestad L; SCHEDULE (SCandinavian HEart transplant everolimus De-novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators. Andreassen AK, et al. Among authors: karason k. Transplantation. 2019 Apr;103(4):781-788. doi: 10.1097/TP.0000000000002445. Transplantation. 2019. PMID: 30211826 Clinical Trial.
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study.
Podesser BK, Rinaldi M, Yona NA, Pulpón LA, Villemot JP, Haverich A, Duveau D, Brandrup-Wognsen G, Gronda E, Costard-Jäckle A, Crespo-Leiro MG, Khazen CS, Viganó M, Segovia J, Mattei MF, Harringer W, Treilhaud M, Karason K, Mangiavacchi M, Laufer G. Podesser BK, et al. Among authors: karason k. Transplantation. 2005 Jan 15;79(1):65-71. doi: 10.1097/01.tp.0000140965.83682.d6. Transplantation. 2005. PMID: 15714171 Clinical Trial.
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.
Arora S, Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Sigurdardottir V, Dellgren G, Erikstad I, Solberg OG, Ueland T, Aukrust P, Gullestad L; SCHEDULE (SCandinavian HEart transplant everolimus De novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators. Arora S, et al. Am J Transplant. 2015 Jul;15(7):1967-75. doi: 10.1111/ajt.13214. Epub 2015 Mar 17. Am J Transplant. 2015. PMID: 25783974 Free article. Clinical Trial.
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study.
Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Rådegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L; SCHEDULE investigators. Andreassen AK, et al. Among authors: karason k. Am J Transplant. 2016 Apr;16(4):1238-47. doi: 10.1111/ajt.13588. Epub 2016 Jan 28. Am J Transplant. 2016. PMID: 26820618 Free article. Clinical Trial.
Design and rationale of the HITTS randomized controlled trial: Effect of High-intensity Interval Training in de novo Heart Transplant Recipients in Scandinavia.
Nytrøen K, Yardley M, Rolid K, Bjørkelund E, Karason K, Wigh JP, Dall CH, Arora S, Aakhus S, Lunde K, Solberg OG, Gustafsson F, Prescott EI, Gullestad L. Nytrøen K, et al. Among authors: karason k. Am Heart J. 2016 Feb;172:96-105. doi: 10.1016/j.ahj.2015.10.011. Epub 2015 Oct 21. Am Heart J. 2016. PMID: 26856221 Review.
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial.
Gullestad L, Eiskjaer H, Gustafsson F, Riise GC, Karason K, Dellgren G, Rådegran G, Hansson L, Gude E, Bjørtuft Ø, Jansson K, Schultz HH, Solbu D, Iversen M. Gullestad L, et al. Among authors: karason k. Transpl Int. 2016 Jul;29(7):819-29. doi: 10.1111/tri.12783. Epub 2016 May 30. Transpl Int. 2016. PMID: 27067532 Free article. Clinical Trial.
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE).
Relbo Authen A, Grov I, Karason K, Gustafsson F, Eiskjaer H, Rådegran G, Gude E, Jansson K, Dellgren G, Solbu D, Arora S, Andreassen AK, Gullestad L. Relbo Authen A, et al. Among authors: karason k. Clin Transplant. 2017 Sep;31(9). doi: 10.1111/ctr.13038. Epub 2017 Jul 19. Clin Transplant. 2017. PMID: 28640529 Clinical Trial.
111 results